This page provides access to Magnera Corporation’s (NYSE: MAGN) SEC filings, offering a structured view of the company’s regulatory disclosures. Magnera is a Pennsylvania‑incorporated specialty materials company listed on the New York Stock Exchange under the symbol MAGN, serving more than 1,000 customers worldwide with components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products for the food and beverage industry.
Through its filings with the U.S. Securities and Exchange Commission, Magnera reports information about its financial condition, results of operations, governance, and executive compensation. Annual reports on Form 10‑K and quarterly reports on Form 10‑Q detail segment performance for the Americas and Rest of World, cash flow from operating activities, capital expenditures, property, plant and equipment, goodwill and intangible assets, and non‑GAAP metrics such as adjusted EBITDA and free cash flow, along with reconciliations.
Current reports on Form 8‑K disclose material events, including quarterly and annual earnings releases, guidance updates, officer departures, and information about the timing of the annual meeting of shareholders. These filings also confirm Magnera’s exchange listing, state of incorporation, and other key registrant details. Definitive proxy statements on Schedule 14A describe board composition, committee structure, corporate governance practices, and the design of executive compensation programs, including pay‑for‑performance elements and stock ownership guidelines.
On Stock Titan, AI‑powered tools summarize lengthy filings so readers can quickly identify major topics such as changes in leverage, cash flow trends, Project CORE transformation activities, and items related to director elections or say‑on‑pay proposals. Users can review real‑time updates as new documents are posted to EDGAR, including Forms 10‑K, 10‑Q, 8‑K, and proxy statements, and use the summaries to focus on sections most relevant to their analysis of MAGN.
Newtyn Management, LLC reports beneficial ownership of 2,760,000 shares (7.7%) of Magnera Corporation. As of March 31, 2026, the Reporting Person may be deemed to beneficially own the aggregate holdings of two managed partnerships: Newtyn TE Partners, LP with 1,757,147 shares and Newtyn Partners, LP with 1,002,853 shares. The filing cites approximately 35.9 million shares outstanding as of February 5, 2026 as the basis for the percentage.
Magnera Corporation common stock ownership update: a group led by Madison Avenue International LP reports beneficial ownership of 1,590,616 shares as of March 31, 2026. The filing states this represents approximately 4.4% of the company based on 35,900,000 shares outstanding as of February 5, 2026. The statement identifies related entities and individuals (Madison Avenue Partners, EMAI Management, Madison Avenue GP, Caraway Jackson Investments LLC, and Eli Samaha) that may be deemed beneficial owners through managerial or ownership relationships.
Morgan Stanley files an amendment reporting beneficial ownership in Magnera Corp Common Stock. The filing shows 1,892,151 shares reported for Morgan Stanley (representing 5.3%) and 1,875,207 shares for Morgan Stanley Capital Services LLC (representing 5.2%), as provided on the cover pages. The filing is signed by an authorized signatory on 05/12/2026.
Magnera Corp ownership update: Cetus Capital VI, L.P. reports beneficial ownership of 2,242,705 shares of Magnera Corp common stock, representing 6.26% of the class. The filing cites 35.8 million shares outstanding as of May 7, 2026 as the basis for the percentage. The Schedule 13G/A is signed by Littlejohn Associates VI, L.P. as general partner, dated 05/11/2026.
Magnera Corporation reported a smaller loss and stronger cash flow for the quarter ended March 28, 2026. Net sales were $796 million, down 3% from $824 million a year ago, as lower selling prices and modest volume declines offset favorable currency.
Net loss narrowed to $18 million from $41 million, with operating income improving to $17 million from $4 million helped by lower restructuring, depreciation and amortization. Year‑to‑date net loss was $52 million on net sales of $1.588 billion.
Cash from operating activities rose sharply to $89 million year‑to‑date from $7 million, yielding free cash flow of $60 million. Magnera held $303 million of cash and $1.899 billion of long‑term debt, and projects fiscal 2026 cash from operations of $170–$190 million and free cash flow of $90–$110 million. The Project CORE restructuring continued, and management again concluded its disclosure controls and procedures were not effective as merger‑related and IT control remediation remains in progress.
Magnera Corporation reported second quarter results for the quarter ended March 28, 2026. Net sales were $796 million, down from $824 million, a 3% decline driven by a $57 million decrease in selling prices and a 2% organic volume decline, partly offset by $48 million of favorable foreign currency. Operating income improved to $17 million from $4 million, while the company recorded a net loss of $18 million versus a $41 million loss a year earlier.
On an adjusted non-GAAP basis, Adjusted EBITDA was $90 million, up 1% from $89 million, supported by a $2 million favorable price-cost spread and a $2 million foreign currency benefit. Year-to-date net sales were $1,588 million compared with $1,526 million, and year-to-date Adjusted EBITDA rose to $183 million from $173 million.
Cash generation strengthened notably. Net cash from operating activities for the first two quarters was $89 million, up from $7 million, leading to free cash flow of $60 million. Cash and cash equivalents were $303 million and current and long-term debt totaled $1,899 million, with stockholders’ equity of $1,039 million. The company will host a conference call on May 7, 2026, to discuss these results.
Magnera Corp Schedule 13G/A Amendment No. 2: The Vanguard Group filed an amendment reporting that, after an internal realignment, the filer and certain affiliated subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538. The filing states amount beneficially owned: 0 and percent of class: 0% for Magnera Corp common stock.
The amendment explains that subsidiaries or business divisions that formerly were deemed beneficial owners will now report disaggregated holdings and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries.
Magnera Corporation reported voting results from its 2026 Annual Meeting of Shareholders. All nine director nominees were elected to serve until the 2027 meeting, with most receiving over 26.9 million votes in favor. Shareholders also ratified Ernst & Young LLP as independent auditor for the fiscal year ending September 26, 2026, with 29,952,530 votes for and 83,137 against. In addition, shareholders gave advisory approval to the Company’s fiscal 2025 named executive officer compensation, with 26,948,106 votes for, 213,281 against, and 7,190 abstentions, alongside 2,883,319 broker non-votes.
RICKERTSEN CARL J reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Carl J. Rickertsen received a grant of 12,998 restricted stock units (RSUs), representing the right to receive an equal number of shares of common stock. The RSUs were awarded at a price of $0.00 per unit as a 2026 director grant.
According to the terms, this grant vests in full and all restrictions lapse one year from the grant date on March 9, 2027. The RSUs have no value until all restrictions lapse on the final vesting date, so their actual benefit depends on future vesting and the company’s share price at that time.
Magnera Corp reported that director Salmon Tom received a grant of 12,998 Restricted Stock Units on the company’s common stock, par value $.01 per share. The grant is classified as a derivative award acquisition with no cash exercise price.
According to the disclosure, these 2026 director RSUs vest in full and all restrictions lapse one year from the grant date. The filing shows 12,998 RSUs outstanding following the transaction, and notes that the units have no value until all restrictions lapse on the final vesting date.